comparemela.com

Latest Breaking News On - Zentera therapeutics - Page 6 : comparemela.com

Zentalis Pharmaceuticals to Present New Clinical and

Updated data from Phase 1 expansion cohort of ZN-c3 in uterine serous carcinoma (USC) will be presented during a mini symposium session.

United statesNew yorkSan diegoJulia deutschAnthony sunAlexandra roySiqing fuHooman izadiExchange commissionAmerican association for cancer researchUniversity of texas md anderson cancer centerZentalis pharmaceuticals incZentalis pharmaceuticalsAmerican associationCancer researchAnnual meeting

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

/CNW/ Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company s planned public.

New yorkUnited statesSoult ukpyolsiSouth koreaHong kongSan franciscoSouth koreanGarheng kongYunyoung nohBrandon suhEli lillyKaiser permanenteTim luFoundation medicineGuardant healthFlatiron health

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

/PRNewswire/ Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company s planned.

New yorkUnited statesSoult ukpyolsiSouth koreaHong kongSan franciscoSouth koreanGarheng kongBrandon suhEli lillyKaiser permanenteTim luPrnewswire lunitFoundation medicineGuardant healthFlatiron health

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

/PRNewswire/ Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company s planned.

New yorkUnited statesSoult ukpyolsiSouth koreaHong kongSan franciscoSouth koreanGarheng kongBrandon suhEli lillyKaiser permanenteTim luPrnewswire lunitFoundation medicineGuardant healthFlatiron health

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia-based global healthcare investors Tybourne Capital Management

New yorkUnited statesSoult ukpyolsiSouth koreaHong kongSan franciscoSouth koreanGarheng kongKostenloser wertpapierhandelBrandon suhEli lillyKaiser permanenteTim luPrnewswire lunitFoundation medicineGuardant health

vimarsana © 2020. All Rights Reserved.